Pfizer image

MSF hits out at ‘astronomical’ vaccine prices

January 20, 2015
Research and Development, Sales and Marketing Doctors Without Borders, GSK, Médicines San Frontières, Pfizer, Vaccine, diphtheria, measles, pertussis, poliomyelitis, tetanus, tuberculosis

Pharma companies have been named and shamed in a report calling on manufacturers to lower the cost of childhood vaccines …

Bennet Building bioscience laboratory image

Bioscience lab opens up in Cambridge

January 20, 2015
Research and Development AstraZeneca, BIA, Babraham Research Campus, Cambridge, Menelas Pangalos

The UK Bennet Building bioscience laboratory doors have been opened during a ceremony at the Babraham Research Campus in Cambridge …

Hospira image

Hospira closing US manufacturing plant

January 20, 2015
Manufacturing and Production, Sales and Marketing Clayton, Hospira, Novo Nordisk, Vancomycin hydrochloride, illinois, manufacturing

US injectable drugs specialist Hospira is to close its Clayton plant in North Carolina affecting 250 workers. Manufacturing of products …

angela-thomas

New vice-chair for Commission on Human Medicines

January 20, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Commission on Human Medicines, angela thomas, chm

Dr Angela Thomas has been appointed as vice-chair of the Commission on Human Medicines (CHM).She replaces Professor Ian Weller who …

FDA image

Regulators ‘more efficient at approving drugs’

January 19, 2015
Research and Development, Sales and Marketing EMA, EMA), FDA, Health Canada, PMDA)., Pharmaceutical and Medical Devices Agency, Swissmedic, TGA, approvals, cirs, reuters

Global regulatory bodies have become faster at approving new drug products more quickly and consistently, according to a new analysis …

Genentech image

Genentech and Human Longevity ink genomics deal

January 19, 2015
Research and Development, Sales and Marketing 23andME, DNA, Genentech, Illumina, hli, human longevity

Genentech is partnering with US genetics firm Human Longevity (HLI) in another 2015 genomics deal to continue its push into …

Ofev image

Boehringer gains EU approval for Ofev

January 19, 2015
Sales and Marketing Boehringer, Esbriet, IPF, InterMune, ingelheim, nintedanib, ofev

The European Commission has approved Boehringer Ingelheim’s Ofev as a treatment for idiopathic pulmonary fibrosis (IPF). The approval follows the …

Roche image

Roche buys French biotech for €470 million

January 19, 2015
Sales and Marketing Foundation, Genentech, Orphan, Roche, TRO19622, olesoxime, sma, trophos

Roche is buying France-based biotech Trophos in a deal worth up to €470 million in order to gain access to …

eric_terhaerdt_astellas

Astellas takes senior head from AstraZeneca

January 19, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, AstraZeneca, eric Terhaerdt

Eric Terhaerdt has been named as the senior vice president of global development operations at Astellas Pharma. Terhaerdt, who joins the …

Rajeev Venkayya, president of Takeda Vaccines image

Interview: Rajeev Venkayya, president of Takeda Vaccine

January 19, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bush, Ebola, Gates, Rajeev Venkayya, Takeda, brett wells, vaccines

 Rajeev Venkayya is the president of the global vaccine business unit at Takeda Pharmaceuticals. He has served as special assistant …

Viekirax and Exviera image

AbbVie Hep C combo pill ready for Europe

January 16, 2015
Medical Communications AbbVie, Exviera, FDA, HIV, Viekira Pak, Viekirax, harvoni, hep C, sovaldi

The European Commission has approved AbbVie’s Viekirax and Exviera for the treatment of chronic hepatitis C (HCV). Viekirax (ombitasvir/paritaprevir/ritonavir) and …

GSK image

GSK double complaint ruled out by PMCPA

January 16, 2015
Medical Communications, Sales and Marketing ABPI, COPD, GSK, PMCPA, Relvar, Seretide

Complaints questioning the promotion of two of GlaxoSmithKline’s chronic obstructive pulmonary disease (COPD) drugs have been ruled out by a …

VBLOC image

FDA approves novel obesity device

January 16, 2015
Medical Communications, Sales and Marketing EnteroMedics, FDA, Novo, VBLOC, diabetes, obesity, type 2

The US Food and Drug Administration has shown the green light to US firm EnteroMedics’ new obesity device VBLOC that …

philippe_goupit_

MedDay appoints senior head from Sanofi

January 16, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Philippe Goupit, Sanofi, medday

Paris-based biotech MedDay has appointed Philippe Goupit as an independent non-executive director. Goupit was until recently the vice president of …

CDF chair: more treatment reviews to come

January 16, 2015
Sales and Marketing CDF, Cancer Drugs Fund, NHS, NHS England, NICE, peter clark

The chair of NHS England’s cancer drugs fund has said there is likely to be more reviews of affordable treatments …

Olysio  image

Janssen privy to new pricing scheme and see NICE nod

January 16, 2015
Sales and Marketing Janssen, NHS, NICE, hep C, hepatitis, olysio, ribavirin, simeprevir

Janssen’s hepatitis C drug Olysio has been approved by NICE whilst also reaching a novel ‘pay if you clear’ pricing …

Sovaldi image

NICE approves Sovaldi

January 16, 2015
Sales and Marketing Gilead, NHS, NICE, hep C, hepatitis, pharma, sofosbuvir, sovaldi

NICE has recommended Sovaldi in final draft guidance and extended its scope, despite concerns over the price of the blockbuster …

Strivrerdi image

Boehringer complaint ruled out by PMCPA

January 15, 2015
Medical Communications, Sales and Marketing ABPI, Boehringer, COPD, PMCPA, Striverdi, olodaterol

A complaint made by a pharmacist stating that the artwork image for Boehringer Ingelheim’s COPD drug Striverdi is misleading has …

BI image

Sanofi and Boehringer partner on biologics manufacturing

January 15, 2015
Manufacturing and Production, Sales and Marketing Boehringer, Sanofi, antibodies, biologics, cardiovascular, diabetes, mabs, manufacturing, monoclonal, oncology

Boehringer Ingelheim will help Sanofi extend its manufacturing capabilities for biologics in a new alliance, the companies have announced. Boehringer’s …

data report

Sharing trial data should be ‘expected norm’ says US think-tank

January 15, 2015
Medical Communications, Research and Development, Sales and Marketing FDA, Goldacre, Institute of Medicine, clinical trials, transparency

Clinical trial data is in the public interest and should be shared no less than 30 days following regulatory approval …

The Gateway to Local Adoption Series

Latest content